Spironolactone Clinical Trials Spironolactone RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Effect of MRA on Cardiovascular Disease in Patients With Hypertension and Hyperaldosteronemia
Conditions:   Hypertension;   Hyperaldosteronaemia Interventions:   Drug: Spironolactone;   Drug: Finerenone;   Other: Blank control Sponsor:   Nanfang Li Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 18, 2023 Category: Research Source Type: clinical trials

Dapagliflozin, Spironolactone or Both for HFpEF
Condition:   Heart Failure With Preserved Ejection Fraction Interventions:   Drug: Dapagliflozin;   Drug: Spironolactone;   Drug: Spironolactone + Dapagliflozin Sponsors:   Universidade do Porto;   Centro Hospitalar De São João, E.P.E. (CHUSJ);   Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 9, 2023 Category: Research Source Type: clinical trials

Dapagliflozin, Spironolactone or Both for HFpEF
Condition:   Heart Failure With Preserved Ejection Fraction Interventions:   Drug: Dapagliflozin;   Drug: Spironolactone;   Drug: Spironolactone + Dapagliflozin Sponsors:   Universidade do Porto;   FMUP;   Centro Hospitalar Universitário de São João, E.P.E.;   Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 9, 2023 Category: Research Source Type: clinical trials